Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Role of Regulation in Optimizing Medicine use KNH/UON Pharmacy Symposium Optimizing Medicine.

Slides:



Advertisements
Similar presentations
CERTIFICATION, REGISTRATION, AND LICENSURE DEBBIE A MCKNIGHT.
Advertisements

PPOA CORPORATE PROFILE. Who we are The Public Procurement Oversight Authority is the organization responsible for overseeing the implementation of the.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
© Safeguarding public health BIOABSORBABLE STENTS: REGULATORY ISSUES DR SUSANNE LUDGATE Clinical Director Medicines and Healthcare products Regulatory.
International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
Regulation of Pharmaceuticals in Kenya
PHCL 328: Introduction to Drug and Poison Information
Objectives Why we need DHCPL Situations that call for a DHCPL Definitions DHCPL itself–content, presentation, process Target audience Current and future.
KEBS ROLE IN STANDARDIZATION AND ENFORCEMENT OF FOOD SAFETY
Zambia Pharmacovigilance Action Plan National Plan Revision Proposal Dr Albert Mwango Mrs Bernice MwaleSeptember 2004.
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
Overview of Medical Devices Sector Saudi Food and Drug Authority (Saudi Arabia) Dr. Saleh Al Tayyar Director General Medical Devices Sector Saudi Food.
Good Pharmacy Practice- GPP Part 7. Quality Management
WHO Traditional Medicine Strategy and Guidelines Dr Arvind Mathur MD, DHA, DNB Cluster Coordinator Family & Community Health WHO-India World Health Organisation.
National Medicine Policy
 Pharmacovigilance – Patient’s standpoint Steve Arlington May 2007.
Traditional & Complementary Medicine in Malaysia [International Conclave on Traditional Medicine, New Delhi, INDIA Nov. 2006] Datuk Dr. M.S. Pillay.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Pharmaceutical Manufacturers Association PMA Status of National Production Capacity of Generic Medicines – Private Sector Perspective Emmanuel Mujuru,
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
The South African perspective
INTRODUCTION TO RA.
43rd KMA Annual Scientific Conference
1 MÉNARD, MARTIN, AVOCATS THE RIGHT TO SAFE CARE LEGAL ISSUES By: Mtre. Jean-Pierre Ménard, Ad. E.
PHARMACOVIGILANCE AND CLINICAL TRIALS DIVISION 20 August 2015 Victoria Falls Protecting Your Right to Quality Medicines and Medical Devices.
Working together to rationalize the use of Anti-TB drugs GROUP 5 Facilitators: Dr Andrey Zagorkiy, MSH and Dr Knut Lönnroth, WHO/HQ.
OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,
ACCESS TO MEDICINES - POLICY AND ISSUES
Zambia’s Porous Borders & the Influx of Medicines.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
ACCREDITED CONSULTANTS PVT LTD. (ACPL) WELCOMES YOU Your PHARMACOVIGILANCE PARTNER.
Development and Implementation of Good Pharmacy Practice Standards in Developing Countries Author: Frokjaer B, International Pharmaceutical Federation.
Pharmacists Perceptions of the Development of Herbal Medicines in Iran
National Public Health Performance Standards Local Assessment Instrument Essential Service:6 Enforce Laws and Regulations that Protect Health and Ensure.
Dr Mary Couper Quality Assurance and Safety of Medicines WHO
Minimum requirements for Pharmacovigilance in countries.
Trade & Access to Medicines in India Centre for Trade & Development
Market Surveillance in the Republic of Moldova Bratislava 2007 Maria Bizgu, MoldovaStandard Market Surveillance in the Republic of Moldova Bratislava.
PHARMACOVIGILANCE PLAN FOR TANZANIA PREPARED BY EMMA & MARY 10 TH SEPTEMBER 2004.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
1 EPI ANNUAL EVALUATION MEETING Kunduchi Beach Hotel th, December 2010 Registration, Inspection and Vaccine Safety Fimbo, A. M Tanzania.
1 Pharmacovigilance & the New National Adverse Drug Reaction (ADR) Reporting System Michael Bonett, Quality Assessor Post-Licensing Directorate Medicines.
1 PHARMACOVIGILANCE & THE NATIONAL ADVERSE DRUG REACTION (ADR) REPORTING SYSTEM Sarah Spiteri Post-Licensing Directorate Medicines Authority.
EU Health Priorities Jurate Svarcaite Secretary General PGEU.
RAC Regulatory Affairs Certification
ROLES AND RESPONSIBILITIES OF TFDA ON ADDO PROGRAM
Detection & monitoring of ADR
Efficacy and Safety of Medicines
EAST AFRICAN COMMUNITY MEDICINES REGULATORY HARMONIZATION (EAC-MRH) PROJECT PROGRESS NAIROB I - KENYA By: EAC - Secretariat.
REGISTRATION OF CERTIFIED PUBLIC SECRETARIES BOARD (RCPSB)
Reasonable Assurance of Safety and Effectiveness: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division.
11 i. Create a national coordinating mechanism for aDSM
Lessons Learned: Past Present and Future Japan-USA Regulatory Interactions Erica Takai, PhD US Food and Drug Administration
Quality Assurance and Safety of Medicines
Pharmacovigilance in Uganda
Jordan Food & Drug Administration
Sudan National Experience in TCM
Helen Lee, European Commission
Regulation of Medical Products & Patient Safety- A Narrative Review
Issues on Dispensing Dr Percy Mahlathi.
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Compounded Drugs and Lack of Premarket FDA-Approval
A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
WORKSHOP ON OPTIMAL PROCUREMENT OF AFFORDABLE AND QUALITY ASSURED LIFE-SAVING COMMODITIES FOR MATERNAL HEALTH KAMPALA, UGANDA - REGULATORY STATUS AND QUALITY.
Saudi Arabia: Veterinary Pharmaceutical Legislations &
Interconnection of good practices: from development to distribution
Presentation transcript:

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Role of Regulation in Optimizing Medicine use KNH/UON Pharmacy Symposium Optimizing Medicine use to Improve Patient Outcome Dr. Fred Siyoi Deputy Registrar 16 th May 2014

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Introduction Pharmacy and Poisons Board is the National Drug Regulatory Authority in Kenya established by Cap 244 laws of Kenya.

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Vision and Mission Mission-To safeguard the health of public by ensuring the Quality, Safety and Efficacy of Medicines Vision- To be a global centre of regulatory excellence

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Medicines play a critical role on the life of human beings hence have to be well regulated.

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Effective medicines regulation promotes and protects public health by ensuring that Medicines are of the required quality, safety and efficacy; Medicines are appropriately manufactured, stored, distributed and dispensed; Illegal manufacturing and trade are detected and adequately sanctioned; Health professionals and patients have the necessary information to enable them to use medicines rationally; Promotion and adverting is fair, balanced and aimed at rational drug use; Access to medicines is not hindered by unjustified regulatory work

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Constitutional Requirements of Health The constitution of Kenya guarantees every citizen the highest standard of health. Section 43. (1) Every person has the right— (a) to the highest attainable standard of health, which includes the right to health care services, including reproductive health care; which also includes access to the highest quality of medicines Section 46. (1) Consumers have the right— (c) to the protection of their health, safety, and economic interests

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Ensuring Quality of medicines The manufacturing of medicines must be under good manufacturing practices standards All products have to be tested in a known laboratory before it is registered by the Board After registration, the products are routinely monitored through post market surveillance where samples are collected randomly and analyzed in the laboratory.

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Ensuring safety of medicines The board evaluates and approves clinical trial applications for studies taking place in Kenya Before registration of a product in Kenya, the dossier is evaluated to ensure the product is safe to be used by Kenyans. There is also Pharmacovigilance which continuously monitors the safety of medicines in the country. The Board together with other organizations also does studies e.g Cohort Event Monitoring (CEM) to look at safety of marketed medicines(AL, TDF)

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Ensuring efficacy of medicines The board does this through; evaluates and approves clinical trial There is also Pharmacovigilance which continuously monitors the safety of medicines in the country.

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Regulating Training and Practice of Pharmacy 1.The Board reviews and approves curriculum of institutions offering pharmacy. 2.The board also regulates the practice of pharmacy by giving annual practice licenses to pharmacy practionners after they have attained the required CPD points so as to ensure continuous development of the practionner

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Challenges 1.The Act we operate under has been overtaken by events 2.New technologies and changing technologies 3.Fewer employees 4.Living in a global village 5.Politics

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Thank you very much

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Our contact … Directorate of Medicines Information and Pharmacovigilance Pharmacy and Poisons Board Lenana Road P.O. Box: Tel: +254-(020) Nairobi KENYA /6 Fax: +254-(020) /

Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya “ You need not be certain… Just be suspicious ” Report all SUSPECTED adverse medicine reactions and poor quality medicines